FDAnews Drug Daily Bulletin
June 7, 2012 | Vol. 9 No. 112
The FDA would see its appropriations reduced by nearly 1 percent under a plan unveiled by the House Tuesday, but advocates of higher funding aren’t yet calling it a defeat.
Over the next several years, the U.S. Food and Drug Administration (FDA) will engage more with its international counterparts through systems that will allow it to share real-time information and resources in a more comprehensive way than is currently possible.
Pharma lobbyists managed to stave off price controls for Medicare Part D, and imports of cheaper drugs from Canada, in 2009 healthcare reform talks with White House officials, a congressional investigation finds.
France’s recently-formed National Security Agency of Medicines and Health Products (ANSM) has announced the launch of new advertising guidelines, which it says will transition the agency from a passive verification system to a system in which advertising must be approved before publication.
Vivus said that it now expects European Union regulators to make a decision on its obesity drug Qnexa no sooner than September.
Senator Edward Kennedy was diagnosed with brain cancer in 2008 and died 15 months later, close to the median survival time for the disease.
Millions of the world’s poorest people could have easier access to life-saving drugs if India introduces an air ticket tax to help fund purchases of cheap medicines for HIV/AIDS, malaria and tuberculosis, a senior UN official said.
Leached pesticides, particles of wood and metal, infectious bacteria, overdosed medicines, underdosed medicines. And, oh yes, that strange moldy and musty scent.
Bausch + Lomb announced today that it has completed its acquisition of ISTA Pharmaceuticals.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.